STROM; Tim-Matthias

Patent Applications and Registrations

Patent applications and USPTO patent grants for STROM; Tim-Matthias.The latest application filed is for "vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives".

Company Profile

0.10.12

STROM; Tim-Matthias - Muenchen DE
Strom; Tim Matthias - Munich N/A DE
Strom; Tim Matthias - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vitamin K Epoxide Recycling Polypeptide Vkorc1, A Therapeutic Target Of Coumarin And Their Derivatives App 20170240867 - OLDENBURG; Johannes ; et al.	2017-08-24
Vitamin K Epoxide Recycling Polypeptide Vkorc1, A Therapeutic Target Of Coumarin And Their Derivatives App 20130318640 - OLDENBURG; Johannes ; et al.	2013-11-28
Methods of diagnosing hypophosphatemic disorders Grant 8,586,317 - Econs , et al. November 19, 2	2013-11-19
KASPP (LRRK2) gene, its production and use for the detection and treatment of neurodegenerative disorders Grant 8,409,809 - Meitinger , et al. April 2, 2	2013-04-02
Methods of Diagnosing Hypophosphatemic Disorders App 20120064544 - Econs; Michael ; et al.	2012-03-15
Kaspp (lrrk2) Gene, Its Production And Use For The Detection And Treatment Of Neurodegenerative Disorders App 20120035072 - Meitinger; Thomas ; et al.	2012-02-09
KASPP (LRRK2) gene, its production and use for the detection and treatment of neurodegenerative disorders Grant 8,029,986 - Meitinger , et al. October 4, 2	2011-10-04
Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives App 20110154520 - Oldenburg; Johannes ; et al.	2011-06-23
Kits for diagnosing a hypophosphatemic disorder Grant 7,947,810 - Econs , et al. May 24, 2	2011-05-24
Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives Grant 7,939,250 - Oldenburg , et al. May 10, 2	2011-05-10
Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders App 20100235933 - Meitinger; Thomas ; et al.	2010-09-16
Fibroblast growth factor (FGF23) polypeptides Grant 7,745,406 - Econs , et al. June 29, 2	2010-06-29
Fibroblast growth factor (FGF23) and methods for use App 20090311792 - Econs; Michael ; et al.	2009-12-17
Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives App 20090094708 - Oldenburg; Johannes ; et al.	2009-04-09
Fibroblast growth factor (FGF23) and methods for use App 20080241946 - Econs; Michael ; et al.	2008-10-02
Antibodies to fibroblast growth factor (FGF23) Grant 7,314,618 - Econs , et al. January 1, 2	2008-01-01
Fibroblast growth factor (FGF23) nucleic acids Grant 7,223,563 - Econs , et al. May 29, 2	2007-05-29
Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives App 20050271644 - Oldenburg, Johannes ; et al.	2005-12-08
Novel fibroblast growth factor (FGF23) and methods for use App 20030181379 - Econs, Michael ; et al.	2003-09-25
Novel fibroblast growth factor ( FGF23) and methods for use App 20020156001 - Econs, Michael ; et al.	2002-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.